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With more than a million seizures of illegal drugs reported annually across Europe, the
variety of psychoactive compounds available is vast and ever-growing. The multitude
of risks associated with these compounds are well-known and can be life threatening.
Hence the need for the development of new analytical techniques and approaches that
allow for the rapid, sensitive, and specific quantitative detection and discrimination of
such illicit materials, ultimately with portability for field testing, is of paramount importance.
The aim of this study was to demonstrate the application of Raman spectroscopy and
surface-enhanced Raman scattering (SERS) combined with chemometrics approaches,
as rapid and portable techniques for the quantitative detection and discrimination
of a wide range of novel psychoactive substances (methcathinone and aminoindane
derivatives), both in powder form and in solution. The Raman spectra of the psychoactive
compounds provided clear separation and classification of the compounds based on
their core chemical structures; viz. methcathinones, aminoindanes, diphenidines, and
synthetic cannabinoids. The SERS results also displayed similar clustering patterns, with
improved limits of detections down to ∼2mM (0.41 g L−1). As mephedrone is currently
very popular for recreational use we performed multiplexed quantitative detection of
mephedrone (4-methylmethcathinone), and its two major metabolites (nor-mephedrone
and 4-methylephedrine), as tertiary mixtures in water and healthy human urine. These
findings readily illustrate the potential application of SERS for simultaneous detection of
multiple NPS as mixtures without the need for lengthy prior chromatographic separation
or enrichment methods.
Keywords: spectroscopy, raman, SERS, drug detection, psychoactive compounds
Muhamadali et al. Detection and Quantification of NPS With Raman and SERS
INTRODUCTION
Novel Psychoactive Substances (NPS) are defined as any
substance able to affect a person’s mental capability or emotional
state (Welter-Luedeke and Maurer, 2016). They have been
reported in the earliest of human records, used by healers in
primitive medicines with compounds like opium, by priests
in religious ceremonies, and in the general population for
recreational use with drugs such as nicotine and caffeine.
According to the 2018 report from the United Nations Office
on Drugs and Crimes, around 275 million people worldwide
have used drugs at least once during 2016, and around 167,750
deaths directly due to drug use have been registered in 2015
(UNODC., 2018). The emergence of hundreds of NPS into
various markets, with little to no understanding of their toxicity,
pharmacodynamics, and long-term side effects (Tracy et al.,
2017), has created a challenge for their detection, identification
and quantification, as well as treatment and control efforts.
Despite the availability of various detection methods such as:
capillary electrophoresis (Nguyen et al., 2015; Saar-Reismaa et al.,
2018), immunoassays (Poklis et al., 1993), nuclear magnetic
FIGURE 1 | Comparative Raman spectra of all samples collected in solid form (A). PCA loadings plot of the Raman spectral data collected from all samples in solid
form (B); this corresponds to the PCA scores plot shown in Figure 3A. Different colors represent the compounds with same core structures (methcathinones in red,
aminoindanes in purple, diphenidines in green, and synthetic cannabinoids in blue).
resonance (NMR) spectroscopy (Balayssac et al., 2014), and DNA
aptameric sensors (Rauf et al., 2017), the current gold standard
techniques for the analysis of such materials are so-called
hyphenated methods. These typically involve a combination
of prior chromatographic separation techniques coupled to
mass spectrometry and include gas or liquid chromatography
mass spectrometry (GC-MS, LC-MS) (McKenzie et al., 2018).
Despite the accuracy and sensitivity of these techniques, there
are some drawbacks, including: not being sufficiently portable,
destructive, time-consuming, requiring skilled personnel, and
being expensive to run and maintain. Therefore, the use of
vibrational techniques such as infrared (Schulz et al., 2004;
Risoluti et al., 2016) and Raman spectroscopy (Penido et al.,
2016), and surface-enhanced Raman scattering (SERS) (Yu et al.,
2018, 2019), has attracted a lot of interest as a reliable alternative
(D’Elia et al., 2015) as these physicochemical methods provide
a portable (hand-held), rapid and cost-effective solution. In
addition to these advantages, these techniques enable on-site
quantitative singular or multiplexed detection and identification
of xenobiotic compounds such as NPS and their metabolites
in human biofluids (Mabbott et al., 2015; Yu et al., 2019).
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Whilst infrared and Raman spectroscopy have been shown to
be valuable tools in forensics, including for the analysis of NPS
(Jones et al., 2016), providing detailed chemical information, due
to their inherent weak signal, these techniques are perceived to
lack the required sensitivity for the detection of compounds at
low concentrations (Stiles et al., 2008). Therefore, the specificity
and selective sensitivity of SERS promotes this approach as a
viable alternative method for such applications, allowing the
detection, and absolute quantification of trace quantities of
target analytes (Goodacre et al., 2018). Several studies in the
literature have reported the application of SERS for quantitative
detection of various drugs such as: caffeine (Alharbi et al.,
2015b), propranolol (Subaihi et al., 2016), 5,6-methylenedioxy-
2-aminoindane (MDAI) (Mabbott et al., 2013), codeine (Subaihi
et al., 2017), tramadol (Alharbi et al., 2015a), phenothiazine
(Ackermann et al., 2007), and amphetamines (Faulds et al., 2002;
Dong et al., 2015; Han et al., 2015).
The primary aim of this study was to demonstrate the
application of Raman spectroscopy and SERS combined with
chemometrics approaches for the quantitative detection and
discrimination of a wide range of NPS (methcathinone and
aminoindane derivatives), both as powders and in solution.
Furthermore, to examine fully the suitability of this approach
as a valid alternative to current methods, a secondary aim was
to illustrate the detection and quantification of mephedrone (4-
methylmethcathinone) and its metabolites (nor-mephedrone and
4-methylephedrine) in a multiplexed system as tertiary mixtures
in water and human urine, in order to translate this approach to
real-world applications.
MATERIALS AND METHODS
Silver nitrate (99.9% purity), trisodium citrate, and sodium
chloride were purchased from Sigma Aldrich (Dorset,
United Kingdom). The target compounds (Table S1) were
synthesized at Manchester Metropolitan University, under
UK Home Office license (No. 337201), and obtained as stable,
white to off-white powders. To ensure the authenticity of
the materials utilized in this study the synthesized samples
were structurally characterized and the purity of all samples
was confirmed by NMR and GC-MS (>99.5% in all cases).
Stock solutions (0.1M) of the samples (S1–S16) were
prepared in de-ionized (DI) water. Samples S17–S23 did
not dissolve in water, thus only Raman spectra of the solid
(powder) were collected. Sodium chloride stock solution
(0.5M) was prepared by dissolving 0.29 g NaCl in 10mL of
DI water.
FIGURE 2 | Comparative SERS spectra of all samples collected in aqueous solution (A). PCA loadings plot of the SERS spectral data collected from all samples (B);
this corresponds to the PCA scores plot shown in Figure 4. Different colors represent the compounds with same core structures (methcathinones in red,
aminoindanes in purple, and diphenidines in green).
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Mid-stream first morning urine samples were collected
in 50mL Falcon tubes. Samples were briefly kept at ∼4◦C
immediately following collection, then transported to the
laboratory and stored at −80◦C within 2 h of collection. Prior to
analysis, samples were allowed to thaw, centrifuged at 5,000 g for
10min at 4◦C and any pellet removed before being used.
Ethical Approval for collection of urine from a single healthy
volunteer was not required and this is in line with local legislation
and is also in line with the 1964 Declaration of Helsinki.
Preparation and Characterization
of Nanoparticles
All glassware were carefully washed in aqua regia (HNO3:HCl
1:3) and deionised water and air-dried at room temperature
before nanoparticle preparation.
Citrate-reduced Ag colloid was prepared by following the
Lee and Meisel (Lee and Meisel, 1982), method. Briefly 90mg
of silver nitrate was dissolved in 500mL deionised water and
heated to boiling. 10mL of 1% w/v trisodium citrate aqueous
solution was then added to the boiling silver nitrate solution,
and left stirring for 20min to stabilize nanoparticle sizes. A
color change from colorless to milky green indicated successful
synthesis of nanoparticles. The colloids were cooled to room
temperature and stored in bottles covered in aluminum foil to
prevent light degradation.
Borohydride-reduced Ag colloid (Lee and Meisel, 1982; Zeiri
et al., 2002). Silver nitrate (0.104 g) was dissolved in DI water
(100mL). A solution of sodium borohydride (0.057 g) was
prepared. Both solutions were cooled separately in ice for 30min.
The ice-cold silver nitrate solution was added dropwise to the
sodium borohydride solution with stirring for 20min. A color
change from colorless to a dark milky yellow was observed. Once
cool, the flask was wrapped in foil to prevent light degradation.
Silver colloid by hydroxylamine reduction (Leopold and
Lendl, 2003). Stock solutions of silver nitrate (0.176 g in 10mL
DI water), sodium hydroxide (0.125 g in 100mL DI water)
and hydroxylamine hydrochloride (1.059 g in 10mL DI water)
FIGURE 3 | 3D PCA scores plots of the Raman spectral data collected from the samples in solid (powder) (A) and aqueous form (0.1M) (B). Different colors represent
the compounds with same core structures (methcathinones in red, aminoindanes in purple, diphenidines in green, and synthetic cannabinoids in blue), while the
symbols represent the individual samples analyzed in this study. TEV = total explained variance.
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were prepared. Sodium hydroxide solution (20mL) was added
to DI water (158mL) and the resulting solution heated with
stirring. Hydroxylamine hydrochloride solution (2mL) was then
added. In a separate flask, silver nitrate solution (2mL) was
diluted with DI water (20mL) and added dropwise to the
sodium hydroxide solution with stirring. Once addition was
complete, the solution was left stirring for 15min. A color change
from colorless to gray/purple was observed. Following this, the
suspension was left to cool and wrapped in foil to prevent
light degradation.
UV-Vis characterization was carried out by collecting
absorbance spectra over a range of 300–800 nm using a Thermo
Biomate 5 spectrophotometer (Thermo Fischer Scientific Inc.,
Massachusetts, USA).
Optimisation of SERS Parameters
For optimization purposes, a stock solution of methcathinone
hydrochloride (sample 1) was prepared to test the synthesized
nanoparticles and to establish the optimal nanoparticles and
conditions (various pH and addition of aggregating agent) for
acquiring the most reproducible SERS signal.
Instrumentation
Raman analysis was undertaken using a Renishaw inVia
confocal Raman microscope (Renishaw Plc., Gloucestershire,
U.K.) equipped with a 785 nm laser. The instrument was
calibrated using a silicon plate focused under a ×50 objective,
where a static spectrum centered at 520 cm−1 for 1 s at 10%
power was collected. Spectral data were collected using theWiRE
3.4 software (Galactic Industries Corp. Salem, NH). All spectra
were acquired using the laser power adjusted on the sample to
∼28 mW.
SERS spectral data of analyte solutions were collected by
mixing 100µL of sample and 200µL of the nanoparticle solution
in a small glass vial, using Delta Nu Advantage portable Raman
spectrometer (Laramie WY, USA) equipped with a 785 nm laser.
Power density on the sample was adjusted to ∼60 mW for
20 s, with three SERS spectral acquisitions per sample. All SERS
spectra were collected from aminimumof three replicate samples
within 100–1,800 cm−1 range, immediately after mixing the
solutions in the glass vials.
Data Analysis
All Raman and SERS spectra were analyzed using MATLAB
software (R2015a) (The Math Works Inc., Natick, USA). Data
were baseline corrected using asymmetric least-squares (AsLS)
algorithms (Eilers, 2003), using an asymmetry parameter of
0.001 and smoothing parameter of 10,000, and auto-scaled.
Principal components analysis (PCA) was carried out to reduce
the dimensionality of the data, and scores plots generated to
investigate the similarities and differences of spectral features (via
loadings plots) of the samples. Partial least squares regression
(PLSR) (Geladi and Kowalski, 1986; Gromski et al., 2015) was
used to generate a series of multivariate regression models using
the spectral data (serial dilutions) of the individual samples. The
number of latent variables (PLS factors) were selected using cross
validation, with subsequent testing on independent hold out data
(test sets).
Multiplexed detection of the target analyte (mephedrone
hydrochloride) and its phase I metabolites (nor-mephedrone
hydrochloride and 4-methylephedrine hydrochloride) in water
and human urine was carried out by generating a set
of univariate models via regression of the integrated areas
of the discriminatory peaks of interest, against the known
concentrations of the analytes.
RESULTS AND DISCUSSION
Raman spectra of all samples collected in solid (S1–S23:
Figure 1A) and liquid (S1–S16: Figure 2A) displayed clear
FIGURE 4 | PCA scores plot of all SERS spectral data. Different colors represent the compounds with same core structures (methcathinones in red, aminoindanes in
purple, and diphenidines in green), while the symbols represent the individual samples analyzed in this study. TEV = total explained variance.
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compound-specific vibrational patterns. Multivariate statistical
approaches were applied to characterize and differentiate the
samples and to see if these were based on core chemical structural
differences. PCA was therefore employed to explore these data
further (Figure 3). As PCA is an unsupervised learning method
any clusters observed would be a natural reflection of any
spectral similarities and/or differences. The PCA scores plot
of the pre-processed (AsLS and auto-scaled) Raman spectral
data collected from the solid (powder) samples (Figure 3A)
did indeed display a clear separation of the samples according
to their core structures. Whilst the diphenidines (samples 14–
18) were separated from all other samples according to PC1
axis (Figure 3A) with a total explained variance (TEV) of
20.8%, the synthetic cannabinoids were clustered on the positive
side of PC2, with a TEV of 16.4%, and away from all other
samples. According to the PC1 loadings plot of the solid samples
(Figure 1B), the most significant vibrational band contributing
to the separation of the diphenidines from all other NPS samples
was the peak at 1,001 cm−1 which can be assigned to aromatic
ring breathing/in-plane C-H bending. This is also apparent in
the Raman spectra (Figure 1A) exhibiting a sharp peak in this
region for all the diphenidines, which is perhaps not surprising
considering the structure of this group of compounds containing
multiple aromatic rings. In addition, the PC2 loadings plot
(Figure 1B) identified the 773 cm−1 peak, corresponding to N-N
asymmetric stretching of indazole (Islam et al., 2018), to be the
most significant feature discriminating between the synthetic
cannabinoids and all other samples.
PCA scores plot of the Raman spectral data collected from
the samples in solution (Figure 3B) displayed similar clustering
patterns, where the diphenidines were again separated from all
other samples according to PC1 axis with a TEV of 29.2%, while
PC3 allowed for further discrimination of the aminoindanes
from methcathinones. The most significant vibrational bands
highlighted by the PCA loadings plot (Figure 2B) of these
samples were also in agreement with those from the solid
samples (Figure 1B).
In order to establish the required optimal condition for
achieving the SERS signal, methcathinone hydrochloride (sample
1) and Rhodamine 6G (0.2mM) was tested with different
nanoparticles (silver borohydride, silver citrate, and silver
hydroxylamine reduced) in NaCl as the aggregation agent at a
range of pH levels (3, 5, 7, and 9). Comparison of the SERS spectra
acquired from the three tested nanoparticles demonstrated
that the silver hydroxylamine reduced nanoparticles provided
the most reproducible spectra, and that the addition of the
aggregation agent did not improve the signal (Figures S1A–C,
S2). Hence, hydroxylamine-reduced Ag nanoparticles without
the addition of an aggregation agent was taken forward and
employed as the optimum SERS substrate. To determine the
optimal pH for SERS analysis, SERS spectra of methcathinone
hydrochloride (sample 1) was collected at different pH
levels and the results suggested pH 7 as the optimum
condition (Figure S1D).
Comparison of the SERS spectra of all 16 samples in solution
(Figure S3) also demonstrated clear vibrational patterns specific
to each of the psychoactive compounds. PCA scores plot of
these SERS data (Figure 4), were consistent with previous
Raman findings (Figure 3), and allowed for the separation of
diphenidines from all other samples according to PC1 axis with
38.1% TEV. Surprisingly, two of the methcathinone samples (1
and 3) also clustered closely with the diphenidines. PC1 loadings
plot of these data (Figure S4), highlighted the vibrational band at
1,028 cm−1 (C-H in plane bending, aromatic stretch) to be the
most significant peak distinguishing between the diphenidines
and the rest of the samples. This finding also explains the
reason for clustering of the two methcathinones (samples 1 and
3) with the diphenidines, as these are the only methcathinone
samples which also displayed a strong vibrational band at
1,028 cm−1 (Figure S3).
In order to determine the limit of detection (LOD) for each of
the compounds via SERS, we followed the procedure as described
in Clayton et al. (1987), Ortiz et al. (2003). Dilution series of
the individual compounds was prepared in water (Table 1), and
the SERS spectra were collected (Figure S5). The PLSR models
were built to predict the concentrations of each compound using
corresponding SERS spectra. The models were validated using
a double cross-validation procedure as described in Westerhuis
et al. (2008). The PLSR models displayed acceptable (0.48–
0.94) coefficient of determination of validation (Q2). Based on
the predictions of these PLS-R models the estimated LODs
varied from the lowest of ∼2mM to the highest of 51mM for
samples 13 and 12, respectively. It is also worth noting that,
a comparison of all spectral data collected from the samples
in solution displayed clear differences between the Raman and
SERS vibrational features and relative intensities, which suggests
that the spectra collected from the NPs mixtures are indeed
SERS signal.
The above findings clearly demonstrated the potential
application of SERS for the detection of various psychoactive
drugs using their intrinsic spectral signatures. However, in a
TABLE 1 | Estimated limits of detection (LOD) of all the compounds using SERS.
Sample No. Conc. rangeImM LOD/mM Q2 of double-CV
1 50.0–3.1 4.25 0.77
2 25.0–1.6 6.05 0.73
3 100.0–3.1 5.62 0.81
4 50.0–1.6 2.44 0.93
5 50.0–3.1 2.99 0.78
6 100.0–6.3 19.13 0.60
7 50.0–1.6 2.45 0.89
8 100.0–1.6 2.21 0.94
9 100.0–3.1 3.37 0.88
10 100.0–1.6 10.94 0.70
11 50.0–3.1 3.21 0.87
12 100.0–3.1 51.01 0.48
13 50.0–1.6 1.99 0.94
14 25.0–1.6 3.60 0.82
15 25.0–1.6 2.46 0.77
16 100.0–1.6 30.86 0.62
Q2 indicates the prediction-linearity of the PLSR models generated for each of the
compounds, from test cross validation samples (i.e., samples not used in the calibration
of the PLS models).
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real biological system many of these xenobiotic compounds
could be metabolized, thus detection of the target compound
as well as its metabolites may play a crucial role in monitoring,
since these metabolites may still be present after the NPS is no
longer detectable. This would also enable a better understanding
of the pharmacokinetics and pharmacodynamics of these
drugs. To give an example, various studies have reported
the potential phase I metabolic pathway of mephedrone
FIGURE 5 | Pharmacokinetic mock-up model for 4-MMC and two of its major metabolites (A). Average metabolite-specific SERS peak areas vs. timepoints for the
multiplex detection experiment carried out in water (B), and urine (C). The letters 4-MMC, NM, and 4-Me, represent 4-methylmethcathinone, and its metabolites
nor-mephedrone and 4-methylephedrine, respectively. The secondary y-axis indicates the detected peak area for NM. Data points presented are average values of
three replicates, with error bars indicating the standard deviation.
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(4-MMC) as: (i) N-demethylation of the primary amine to
form normephedrone; (ii) reduction of the β-keto moiety
to the respective alcohol named dihydromephedrone; and
(iii) oxidation of the tolyl moiety to the corresponding
alcohol, 4-hydroxytolylmephedrone which undergoes
further oxidation (Khreit et al., 2013; Pozo et al., 2015;
Elbardisy et al., 2019).
As 4-MMC (sample 4) and two of its main metabolites,
nor-mephedrone (Sample 7) and 4-methylephedrine (sample 8),
were successfully detected in this study with reasonable LOD
values (Table 1), multiplexed detection of these compounds in
both water and urine were investigated. In order to mimic
the pharmacokinetics of 4-MMC in a real biological system,
and based on the reported findings in the literature (Green
et al., 2014; Olesti et al., 2017), it was assumed that metabolism
to nor-mephedrone was twice that of the metabolism to
4-methylephedrine throughout the experiment. Two sets of
samples were prepared in water and human urine, where the
concentration of 4-MMC was decreased while the concentration
of nor-mephedrone and 4-methylephedrine were gradually
increased to mimic a real-life scenario in a biological system
(Table S2). Thus, the sample numbers were referred to as time-
points to assist such visualization. It is also worth noting that the
combined overall concentration of all three compounds in each
sample was kept constant.
The specific vibrational bands for each of the metabolites were
identified (Figure S6), and their corresponding peak areas in
both water and urine samples were plotted against time-points
(sample numbers) (Figure 5). These results clearly displayed the
decrease of 4-MMC levels, while its two metabolites exhibited an
increasing trend with time. In addition, the known concentration
of 4-MMC and its metabolites in the solutions were also plotted
against the detected peak areas to examine the linearity of
the SERS signal (Figure 6). Although the SERS signal of 4-
MMC did not display a linear trend at higher concentrations
in the urine samples (>13.1mM) (Figure 6D), probably due
FIGURE 6 | Average metabolite-specific peak areas vs. known concentration for the multiplex detection experiment carried out in water (A–C), and urine (D–F). The
letters 4-MMC, NM, and 4-Me, represent 4-methylmethcathinone, and its metabolites nor-mephedrone and 4-methylephedrine, respectively. Data points presented
are average values of three replicates, with error bars indicating the standard deviation.
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to the complexity of the background matrix (urine) causing
saturation of the nanoparticles, all other samples exhibited a
linear correlation with a correlation coefficient (R2) in the range
of 0.77–0.97.
CONCLUSION
The emergence of NPS, such as cathinones, tryptamines,
synthetic cannabinoids, and piperazines, and the vast range of
potentially serious side-effects associated with these substances
(Hillebrand et al., 2010), illuminates the importance of having
rapid, quantitative testing, and detection analytical methods.
Thus, the aim of this study was to demonstrate the application
of Raman spectroscopy and SERS for quantitative detection and
discrimination of a range of NPS as powders and in solution.
The detailed and specific vibrational signatures acquired from the
Raman and SERS spectral data allowed for clear PCA clustering
and separation of the investigated compounds according to
their core chemical structures and suggesting that classification
would be feasible. To our knowledge this is the first time that
multivariate statistics has been applied to Raman or SERS data
from NPS that reveal core chemical structures and this may be
useful when newNPS are synthesized that have not been detected
before as they should cluster with their core structural motif.
The SERS analysis provided LODsmostly ranging between 2.0
and 5.6mM. Although values in this range are low enough to
compare favorably with some techniques currently being used in
drug detection, such as microcrystalline testing, they are perhaps
not low enough to compare with the current gold standard
laboratory techniques such as GC-MS. However, SERS does have
the advantage of providing accurate and reliable data rapidly
(1min sample analysis time), with the considerable bonus of
the potential of using portable and handheld technologies that
could be deployed for on-site testing of samples. Be that point-
of-care within clinical settings or in-field testing/identification
wherever these psychoactive substances are found. Finally, the
successful multiplexed quantitative detection of mephedrone (4-
MMC) and two of its main phase I metabolites, nor-mephedrone
and 4-methylephedrine, by SERS in both water and human urine,
demonstrates further the potential application of this approach
for direct detection and quantification of multiple target analytes
in human biofluids.
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